GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

GETI.B

209.4

+0.29%↑

CAMX

723.5

-0.07%↓

VITR

137

+1.78%↑

EKTA.B

44.3

-1.6%↓

AMBEA

126.1

+0.08%↑

Home・Aktien・BioArctic AB

B
BioArctic AB

Geschlossen

290 -7.29

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

272.2

Max

312.8

Schlüsselkennzahlen
By Trading Economics
Einkommen	-979M 97M
Verkäufe	-897M 392M
KGV Branchendurchschnitt	25.665 35.733
EPS	1.09
Gewinnspanne	24.623
Angestellte	119
EBITDA	1.1B 1.1B

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	6.6B 27B
Vorheriger Eröffnungskurs	297.29
Vorheriger Schlusskurs	290

BioArctic AB Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Sept. 2025, 16:09 UTC

Akquisitionen, Fusionen, Übernahmen

BBVA Clears Last Hurdle to Open $17.4 Billion Bid to Sabadell Shareholders -- 2nd Update

5. Sept. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

5. Sept. 2025, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Assets of Auction Include Nationwide Retail Distribution Network of More Than 4,000 Branded Service Stations >BLUWU

5. Sept. 2025, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Assets of Auction Include Lubricant and Blending Plants Supporting Specialty Fuels and Lubricants >BLUWU

5. Sept. 2025, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Assets of Auction Include Midstream Infrastructure, Including Pipelines and Terminals Such as the Sour Lake Crude Pipeline >BLUWU

5. Sept. 2025, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Assets of Auction Include Refineries at Lake Charles, La., Lemont, Ill., Corpus Christi, Texas, With Combined Refining Capacity Exceeding 800,000 Barrels per Day >BLUWU

5. Sept. 2025, 20:33 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Proposal Would Provide $3.2B Settlement for Holders of PDVSA 2020 Bonds to Be Paid Either in Cash or in Shrs of Publicly Listed Entity That Will Own Citgo >BLUWU

5. Sept. 2025, 20:33 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water: Proposal Would Provide Cash or Stk Distributions to PDV Holding Inc.'s General Creditors >BLUWU

5. Sept. 2025, 20:31 UTC

Akquisitionen, Fusionen, Übernahmen

Blue Water Acquisition Corp. III: Announces Submission of $10B Bid for PDV Holding Inc., Parent of Citgo Petroleum Corp.

5. Sept. 2025, 20:20 UTC

Ergebnisse

These Stocks Moved the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5. Sept. 2025, 19:23 UTC

Market Talk

Oil Futures Extend Losses Ahead of OPEC+ Meeting -- Market Talk

5. Sept. 2025, 19:22 UTC

Ergebnisse

Week's Best: Insurance Costs, Like Sea Levels, Are Rising -- Barrons.com

5. Sept. 2025, 19:17 UTC

Market Talk

U.S. Natural Gas Snaps Winning Streak -- Market Talk

5. Sept. 2025, 18:59 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Kenvue, Guidewire, and More -- Barrons.com

5. Sept. 2025, 18:35 UTC

Market Talk

BMO Leans Toward September Canada Rate Cut After 'Exceptionally Weak' Jobs Report -- Market Talk

5. Sept. 2025, 17:25 UTC

Market Talk

Bets on Hefty Fed Cut Seen as Exaggerated -- Market Talk

5. Sept. 2025, 17:20 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 414 -- Market Talk

5. Sept. 2025, 17:17 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. Sept. 2025, 17:17 UTC

Market Talk

Bank of Canada Policy Seen Moving to Expansionary Territory -- Market Talk

5. Sept. 2025, 17:03 UTC

Market Talk

Bank of Canada Expected to Cut, But Inflationary Pressures Remain a Concern -- Market Talk

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Commencing at Market Open on Sept 8, Common Stk Will Trade on Nasdaq Under New Ticker Symbol 'MCGA' >YORK

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Will Be Renamed to Trump Media Group CRO Strategy Upon Closing of Combination Between Yorkville, Trump Media & Technology Group Corp. and Crypto.com >YORK

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition Corp.: Announces Ticker Symbol Change to 'MCGA' Ahead of Trump Media Group CRO Strategy, Inc. Listing

5. Sept. 2025, 16:39 UTC

Akquisitionen, Fusionen, Übernahmen

Yorkville Acquisition: Outstanding Publicly Traded Units and Warrants Will Trade on Nasdaq Under New Ticker Symbols 'MCGAU' and 'MCGAW', Respectively >YORK

5. Sept. 2025, 16:37 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Global Equities Roundup: Market Talk

5. Sept. 2025, 16:37 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Global Energy Roundup: Market Talk

5. Sept. 2025, 16:37 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Strathcona Buys Up More MEG Shares In Effort to Scuttle Cenovus Deal -- Market Talk

5. Sept. 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

5. Sept. 2025, 16:16 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Broadcom, Nvidia, Lululemon, Tesla, Samsara, Guidewire, and More -- Barrons.com

5. Sept. 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

Peer-Vergleich

Kursveränderung

BioArctic AB Prognose

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.